Literature DB >> 12803393

Systemic uptake of buprenorphine by cats after oral mucosal administration.

S A Robertson1, P M Taylor, J W Sear.   

Abstract

The plasma concentration of buprenorphine was measured by radioimmunoassay in six female cats after the administration of 0.01 mg/kg (0.033 ml/kg) buprenorphine hydrochloride solution into the side of the cat's mouth. Blood samples were taken through a preplaced jugular catheter before and one, two, four, six, 10, 15, 30, 45 and 60 minutes, and two, four, six, 12 and 24 hours after the dose was administered. The buprenorphine was accepted well by all the cats and did not cause salivation or vomiting. Its median peak plasma concentration was 7.5 ng/ml and was reached after 15 minutes. The pharmacokinetic data were similar to the pharmacokinetic data obtained after the intramuscular and intravenous administration of buprenorphine to cats from the same colony, suggesting that the mucosal route of administration should be as effective as intravenous and intramuscular injections. In addition, the pH of the oral cavity of 26 cats was measured with pH paper, and 100 cat owners were asked their preferred method of administering drugs to cats. The pH of the cats' mouths was between 8 and 9, and the technique preferred by the cat owners was the use of drops placed in the mouth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12803393     DOI: 10.1136/vr.152.22.675

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

Review 1.  Buprenorphine in cancer pain.

Authors:  Mellar P Davis
Journal:  Support Care Cancer       Date:  2005-07-12       Impact factor: 3.603

2.  Sedative and cardiopulmonary effects of buprenorphine and xylazine in horses.

Authors:  Fernando S F Cruz; Adriano B Carregaro; Melissa Machado; Rômulo R Antonow
Journal:  Can J Vet Res       Date:  2011-01       Impact factor: 1.310

Review 3.  A review of the studies using buprenorphine in cats.

Authors:  P V M Steagall; B P Monteiro-Steagall; P M Taylor
Journal:  J Vet Intern Med       Date:  2014-03-21       Impact factor: 3.333

4.  Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs.

Authors:  Hiroko Enomoto; Lydia Love; Melanie Madsen; Amber Wallace; Kristen M Messenger
Journal:  J Vet Pharmacol Ther       Date:  2022-04-21       Impact factor: 1.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.